Late gadolinium enhancement CMR in primary mitral regurgitation

Caroline M Van De Heyning1, Julien Magne, Luc A Piérard

  • 1GIGA Cardiovascular Sciences, Heart Valve Clinic, Department of Cardiology, CHU Sart Tilman, University of Liège Hospital, Liège, Belgium; Department of Cardiology, University of Antwerp Hospital, Edegem, Belgium.

Abstract

Insights

Late gadolinium enhancement on cardiovascular magnetic resonance (LGE CMR) may indicate myocardial fibrosis in patients with asymptomatic primary mitral regurgitation (MR). This finding is associated with left ventricular remodeling, suggesting potential implications for risk stratification.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac MRI

Background:

  • The optimal timing for surgical intervention in severe asymptomatic primary mitral regurgitation (MR) remains a clinical challenge.
  • Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) can identify myocardial fibrosis and is linked to adverse outcomes in various heart conditions.

Purpose of the Study:

  • To determine the prevalence and clinical significance of LGE in patients with asymptomatic primary MR.
  • To explore the association between LGE and left ventricular (LV) remodeling in this patient cohort.

Main Methods:

  • Prospective study including 41 patients with moderate to severe primary MR without overt LV dysfunction.
  • Exclusion of patients with coronary artery disease, arrhythmias, or significant concomitant valvular disease.
  • All participants underwent transthoracic echocardiography and LGE CMR.

Main Results:

  • Interpretable LGE CMR images were obtained in 39 patients; 12 (31%) showed delayed contrast uptake in the LV wall.
  • LGE patterns included infarct (n=3), mid-wall fibrosis (n=7), and combined patterns (n=2).
  • Patients with LGE exhibited significantly larger LV end-systolic (39±4 vs. 34±5 mm) and end-diastolic diameters (57±5 vs. 50±5 mm) compared to those without LGE.

Conclusions:

  • The presence of delayed enhancement on CMR in primary MR is associated with left ventricular remodeling.
  • Further research is required to ascertain if LGE CMR can predict unfavorable outcomes or enhance risk stratification in asymptomatic primary MR.

Related Concept Videos

Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
926
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
550
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
670
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
593
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K